NCT00672607View on ClinicalTrials.gov

a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)

PHASE2CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Premenstrual Syndrome
Interventions
DRUG

extracts of Vitex agnus castus tablets

orally, one tablet daily. Apply for a period of 3 months. Do not interrupt during menses period.

DRUG

Placebo

Placebo

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Schwabe-Wenex International Ltd

INDUSTRY

NCT00672607 - a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS) | Biotech Hunter | Biotech Hunter